News for 'Sun Pharma'

Consumer goods firms likely to see an upswing after year of lull

Consumer goods firms likely to see an upswing after year of lull

Rediff.com24 Jul 2024

The Budget proposals are expected to boost the fortunes of consumer goods and fast-moving consumer goods companies, which have been struggling with poor consumer demand for more than a year. The Budget announcements, such as the increase in standard deduction by Rs 25,000 for income-tax payers and slab revisions, will put more money in their hands, boosting consumer demand. Private consumption is also likely to benefit from a new scheme to offer internships to 10 million youths in the country's top 500 companies.

Sensex tanks 668 points on profit-booking

Sensex tanks 668 points on profit-booking

Rediff.com29 May 2024

Benchmark equity indices Sensex and Nifty declined nearly 1 per cent on Wednesday, falling for the fourth day running amid profit-taking by cautious investors ahead of the results of the Lok Sabha polls. The 30-share BSE Sensex declined 667.55 points or 0.89 per cent to settle at 74,502.90. It went below the 75,000 mark to hit the day's low of 74,454.55, plunging 715.9 points or 0.95 per cent.

IT & pharma stocks on funds' radars after fall

IT & pharma stocks on funds' radars after fall

Rediff.com8 Dec 2016

This is a shift as until recent months, fund managers were reducing exposure to these sectors.

Money went to BJP, arrest JP Nadda: AAP counters ED charges

Money went to BJP, arrest JP Nadda: AAP counters ED charges

Rediff.com23 Mar 2024

Atishi alleged that the BJP received "proceeds of crime" in its bank accounts

'Shah Rukh's Words Found Me When I Needed Them Most'

'Shah Rukh's Words Found Me When I Needed Them Most'

Rediff.com6 Aug 2024

'SRK couldn't have been nicer, empathetic, more sharing and interactive. It really was a wonderful moment.'

After showing signs of recovery, pharma sales dip in July

After showing signs of recovery, pharma sales dip in July

Rediff.com11 Aug 2020

Growth has been under pressure since the lockdowns related to Covid-19 started and fresh prescription generations slowed.

USFDA warns Aurobindo Pharma

USFDA warns Aurobindo Pharma

Rediff.com23 May 2011

Company had earlier received an import alert in February this year from the US Food and Drug Administration.

Sensex scales 76K, but ends down in volatile trade

Sensex scales 76K, but ends down in volatile trade

Rediff.com27 May 2024

From the Sensex firms, Wipro, NTPC, Sun Pharma, Mahindra & Mahindra, ITC and Reliance Industries were among the biggest laggards. IndusInd Bank, Axis Bank, Bajaj Finance, HDFC Bank, Larsen & Toubro and State Bank of India were among the major gainers.

Sensex revisits 74K; Nifty climbs 168 points

Sensex revisits 74K; Nifty climbs 168 points

Rediff.com25 Apr 2024

State Bank of India, NTPC, Nestle, Sun Pharma, JSW Steel, ITC, Mahindra & Mahindra and HCL Technologies were among the other major gainers.

Sensex closes flat, Nifty slips on profit taking

Sensex closes flat, Nifty slips on profit taking

Rediff.com6 May 2024

From the Sensex basket, Kotak Mahindra Bank jumped 5 per cent after the company reported a 25 per cent growth in its March quarter net profit at Rs 5,302 crore, limited by a drop in the core income due to narrow interest margins. Tata Consultancy Services, Hindustan Unilever, Mahindra & Mahindra, Sun Pharma, Tech Mahindra and IndusInd Bank were among the other major gainers. Titan tanked 7 per cent after its March quarter earnings failed to cheer investors.

Top Kannada hero Darshan, actress Pavithra held in murder case

Top Kannada hero Darshan, actress Pavithra held in murder case

Rediff.com11 Jun 2024

Leading Kannada film actor Darshan Thoogudeepa was arrested on Tuesday in connection with the murder of a man who allegedly made "derogatory" comments against his close friend, police sources said.

Sensex ends up 105 points; metal, auto shares shine

Sensex ends up 105 points; metal, auto shares shine

Rediff.com18 Mar 2024

From the Sensex basket, Tata Steel jumped over 5 per cent. Mahindra & Mahindra, JSW Steel, Tata Motors, Axis Bank, Sun Pharma, Reliance Industries and Maruti were the other biggest gainers. Infosys, Tata Consultancy Services, Titan, Wipro, Hindustan Unilever and Nestle were among the laggards.

Sun Pharma acquires US-based Pharmalucence

Sun Pharma acquires US-based Pharmalucence

Rediff.com16 Jul 2014

Drug major Sun Pharmaceutical Industries has acquired US-based Pharmalucence Inc for an undisclosed amount.

Sun Pharmaceutical's vital signs: A strong dose of valuation multiples

Sun Pharmaceutical's vital signs: A strong dose of valuation multiples

Rediff.com13 Nov 2023

Bolstered by an impressive performance in the global specialty business and outstanding results in the Indian market, Sun Pharmaceutical Industries, the largest pharmaceutical (pharma) company in the country, showcased a strong performance in the July-September quarter (second quarter, or Q2) of 2023-24 (FY24).

Sensex falls 379 pts on profit taking in bank & IT stocks

Sensex falls 379 pts on profit taking in bank & IT stocks

Rediff.com2 Jan 2024

Among the Sensex firms, Kotak Mahindra Bank, UltraTech Cement, Mahindra & Mahindra, Larsen & Toubro, ICICI Bank, IndusInd Bank, Wipro and Hindustan Unilever were the major laggards. Sun Pharma, Bajaj Finance, Bharti Airtel, Reliance Industries, Bajaj Finserv and Titan were among the winners.

Indian pharma's Trump fears

Indian pharma's Trump fears

Rediff.com1 Feb 2017

Industry fears tougher US stance on IP after President Donald Trump asserted that foreign countries must pay a fair share for drug development costs. Aneesh Phadnis reports.

Union Budget 2024 remains largely neutral for stock markets in India

Union Budget 2024 remains largely neutral for stock markets in India

Rediff.com25 Jul 2024

Overall market reaction to the Budget was neutral. Investors absorbed the changes to the tax rates (positive for salaried class) and capital gains taxes (CGTs, negative due to the removal of indexation and increases. Other proposals largely pertain to supporting rural development, buybacks taxed as dividends, Custom duty changes that impact multiple sectors, higher outlays for clean energy, etc. There's some moderation in the growth of capex outlay across defence, fer

Markets stage smart recovery; Sensex rises 191 points

Markets stage smart recovery; Sensex rises 191 points

Rediff.com22 Mar 2024

From the Sensex basket, Sun Pharma, Maruti, IndusInd Bank, Titan, ITC, Tata Motors, Larsen & Toubro and JSW Steel were the major gainers. On the other hand, Infosys, Wipro, HCL Technologies, Tata Consultancy Services, Tech Mahindra and Bajaj Finserv were among the laggards.

Why Japan is betting big on Indian pharma cos

Why Japan is betting big on Indian pharma cos

Rediff.com26 Jan 2017

One reason Japan is betting highly on Indian pharma is that these companies have strong cash flows, low leverage and high debt capacity for medium to large sized acquisitions.

Nirma's new clothes: The journey of detergent brand towards healthcare

Nirma's new clothes: The journey of detergent brand towards healthcare

Rediff.com12 Oct 2023

Nirma's tryst with the pharmaceutical space started in 2006 when it acquired the ailing Core Healthcare in a deal reported to be worth Rs 300 crore. The Ahmedabad-based manufacturer of intravenous fluids was subsequently renamed Nirlife. Pharma industry insiders say Nirma, which broke open the detergent market in the 1990s with low prices and massive advertising, tried an encore of the low-price strategy in pharma, but with mixed results.

Why Drug Prices Won't Increase This Year

Why Drug Prices Won't Increase This Year

Rediff.com5 Apr 2024

The government has been stringent with pricing changes. Prices of 651 essential medicines came down from April 1, 2023 by 6.73 per cent with the government capping ceiling prices of these drugs.

Indian Biz Sees Hope After Bangladesh SC Order

Indian Biz Sees Hope After Bangladesh SC Order

Rediff.com22 Jul 2024

'Bilateral trade has suffered seriously because of the growing unrest.' 'There is a standstill on both sides amid the curfew.'

'Pradhan Mantri Hafta Vasuli Yojana': Cong on electoral bonds

'Pradhan Mantri Hafta Vasuli Yojana': Cong on electoral bonds

Rediff.com18 Mar 2024

"Remember, the IT Department and the ED implement the Pradhan Mantri Hafta Vasuli Yojana. The State Bank of India implements the #ElectoralBondScam. And at the end of the day, all of these institutions report to the same person: the Finance Minister," Ramesh alleged.

Stock markets rebound as GST revenues hit record in April

Stock markets rebound as GST revenues hit record in April

Rediff.com2 May 2024

From the Sensex basket, Power Grid, Asian Paints, Tata Motors, Tata Steel, NTPC, Sun Pharma, Mahindra & Mahindra, HDFC Bank, Tata Consultancy Services and JSW Steel were among the major gainers. Kotak Mahindra Bank, Bharti Airtel, Axis Bank, Wipro, ICICI Bank and IndusInd Bank were among the laggards.

Pharma stocks on a booster dose

Pharma stocks on a booster dose

Rediff.com1 Mar 2014

Better-than-expected financial results in Q3 due to higher revenue growth and margins in key markets fuel the rally

Daiichi Sankyo to offload stake in Sun Pharma

Daiichi Sankyo to offload stake in Sun Pharma

Rediff.com20 Apr 2015

Daiichi won't remain a major shareholder in Sun Pharma.

Modi @ 3.0: Sensex races past 76K, Nifty rises 733 points

Modi @ 3.0: Sensex races past 76K, Nifty rises 733 points

Rediff.com3 Jun 2024

Larsen & Toubro, Axis Bank, Reliance Industries, UltraTech Cement, Mahindra & Mahindra, IndusInd Bank, ICICI Bank and Tata Steel were the other big gainers. Sun Pharma, HCL Technologies, Asian Paints, Nestle and Infosys were the laggards.

Investors richer by Rs 13.78 lakh cr in exit poll rally

Investors richer by Rs 13.78 lakh cr in exit poll rally

Rediff.com3 Jun 2024

Investors' wealth jumped Rs 13.78 lakh crore on Monday as the benchmark equity index Sensex hit its lifetime high after exit polls predicted a massive win for the BJP-led NDA in the Lok Sabha polls. The 30-share BSE Sensex jumped 2,777.58 points or 3.75 per cent to hit a record peak of 76,738.89 in early trade. The benchmark finally ended at 76,468.78, registering a sharp rally of 2,507.47 points or 3.39 per cent.

Financial, pharma stocks give Sensex a 359-point boost

Financial, pharma stocks give Sensex a 359-point boost

Rediff.com10 Jun 2021

On the Sensex chart, Bajaj Finance, Bajaj FinServ, SBI, IndusInd Bank, Dr Reddy's, Tech Mahindra, ITC and Kotak Bank were the prominent gainers - rising up to 7.29 per cent. NSE Nifty climbed 102.40 points to end at 15,737.75.

Pharma sector can be a good bet

Pharma sector can be a good bet

Rediff.com17 Nov 2015

Analysts say those taking exposure through stocks could look at firms focused on domestic business

'Power shifts to chemists instead of doctors'

'Power shifts to chemists instead of doctors'

Rediff.com22 Aug 2023

'Whichever company offers better incentives, the chemist would prefer it.'

'Gave you my best': Biden passes the baton to Kamala

'Gave you my best': Biden passes the baton to Kamala

Rediff.com20 Aug 2024

Harris, 59, is scheduled to formally accept the Democratic Party's presidential nomination on Thursday to take on Republican rival Donald Trump, 78, in the November 5 election.

Markets hit all-time peaks on buying in banking, oil and auto

Markets hit all-time peaks on buying in banking, oil and auto

Rediff.com23 May 2024

Benchmark stock indices Sensex and Nifty rallied more than 1.6 per cent to close at lifetime high levels on Thursday following buying in banking, oil and auto shares and a record dividend payout by the RBI to the government. Regaining the 75,000 level after its best single-day gain since January 29, the 30-share BSE Sensex closed at all-time peak of 75,418.04, up by 1,196.98 points or 1.61 per cent over the last close.

Nifty hits new peak, Sensex up 282 points

Nifty hits new peak, Sensex up 282 points

Rediff.com19 Feb 2024

Among Sensex shares, Bajaj Finserve, ICICI Bank, Bharti Airtel, Bajaj Finance, Sun Pharma, Maruti Suzuki, ITC, and Nestle were the lead gainers. On the other hand, L&T Wipro, IndusInd Bank and TCS and Tata Motors were the lead losers.

Karnataka rolls back quota bill for Kannadigas in jobs

Karnataka rolls back quota bill for Kannadigas in jobs

Rediff.com17 Jul 2024

The Karnataka government on Wednesday put the reservation bill for Kannadigas in private firms on hold amid fierce criticism from business leaders and tech tycoons.

7 Indian pharma players race to develop COVID-19 vaccine

7 Indian pharma players race to develop COVID-19 vaccine

Rediff.com19 Jul 2020

Bharat Biotech, Serum Institute, Zydus Cadila, Panacea Biotec, Indian Immunologicals, Mynvax and Biological E are among the domestic pharma firms working on the coronavirus vaccines in India.

'Largecaps appear attractive'

'Largecaps appear attractive'

Rediff.com30 Nov 2023

'Auto, pharma, and industrials have delivered well in the recent quarter, while businesses like quick-service restaurants, consumer staples, and durables have underperformed in volume growth.'

Markets tank 1%, Sensex ends down 793 points

Markets tank 1%, Sensex ends down 793 points

Rediff.com12 Apr 2024

From the Sensex basket, Sun Pharma, Maruti, Power Grid, Titan, JSW Steel, Tech Mahindra, Larsen & Toubro and State Bank of India were the major laggards. Tata Motors, Tata Consultancy Services and Nestle were the gainers.

Stock Market: Which Sectors Delivered?

Stock Market: Which Sectors Delivered?

Rediff.com12 Jan 2024

The biggest bounce is in the realty sector, where the industry index jumped 80%. There's been a turnaround also in automobiles and ancillaries (up 45%). The pharma and health care indices have a welcome return of roughly 35%.

Markets snap 4-day winning run; Sensex down 195 points

Markets snap 4-day winning run; Sensex down 195 points

Rediff.com5 Mar 2024

Among Sensex firms, Bajaj Finserv and Bajaj Finance fell by over 4 per cent each. Nestle, Infosys, Tata Consultancy Services, Wipro, UltraTech Cement, HCL Technologies, Larsen & Toubro and Hindustan Unilever were the other major laggards. Bharti Airtel, State Bank of India, Sun Pharma and NTPC were among the gainers.